Oncology Times

Lymphoma & Leukemia Resource Center

Featured Content

This collection of content will continually bring you the latest news, research and FDA approvals relating to leukemia and lymphoma.

 

New Video! Accelerated Pace of Advances

William G. Wierda, MD, PhD, section chief, Chronic Lymphocytic Leukemia, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, discusses the exciting advances in CLL over the past 5 years.

More Videos

New Article! New Study Suggests Antibody-Based Drug Safe in Treating CLL

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic lymphocytic leukemia (CLL) cells. 

Read More

New Article! Combination Therapy as First-Line Approach for Chronic Lymphocytic Leukemia

The phase III iLLUMINATE (PCYC-1130) trial met its primary endpoint of improvement in progression-free survival (PFS). The study evaluated ibrutinib in combination with obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) patients.

Read More

Free Downloads
The Bethesda Handbook of Clinical Hematology
  • Chronic Lymphocytic Leukemia Inhye E. Ahn, Clare Sun, and Adrian Wiestner
  • Non- Hodgkin Lymphomas              Richard F. Little

Download Now

Loading